Rochester General Hospital continues to lead the way in women’s healthcare by offering the latest FDA-approved technology to screen women who have dense breast tissue. It’s estimated that upwards of 50 percent of women have that condition which makes detecting small cancers more difficult during routine mammography.
“The Automated Breast Ultrasound System (ABUS) at Rochester General Hospital is now being used to screen asymptomatic women with dense breast tissue and no prior interventions,” said William Bowen MD, MS, Chief of Women’s Imaging for Rochester Regional Health System. “Research shows that ABUS technology used along with mammography has the potential to find more than 35 percent additional cancers that would not have been detected using mammography alone.”
In January of 2013, New York State began requiring that physicians notify women whose mammography indicates they have dense breast tissue – a condition that Dr. Bowen says is more common in younger women.
It is known, according to multiple large studies, that dense breast tissue -- by itself, independent of other risk factors -- can increase the risk of developing breast cancer. Moreover, a study in the New England Journal of Medicine shows that dense breast tissue can mask the appearance of tumors.
For more information about ABUS, and to schedule an appointment, please call (585) 922-XRAY (9729)
Monday, July 15, 2019
The expansion is the first phase of a $4.5 million project to expand cancer services at Linden Oaks and it will greatly improve access to care for patients with breast cancer and other breast conditions.Read News Article
Wednesday, June 26, 2019
The new Medical Village features a new OB/GYN, cardiac and pulmonary rehab as well as physical, occupational and speech therapy.Read News Article